He is nicknamed the "
Doctor of America
".
Asked by
J
journal Sunday
, Anthony Fauci, advisor for public health Biden, was optimistic about the US vaccination campaign: with more than 3 million vaccinations per day, and the opening of vaccine to all adults on April 19, the United States redoubled its efforts.
However, a shadow lingers on the picture.
Even with the tripling of injections in recent weeks, the high level of Covid-19 infection (67,000 last week) and the number of deaths (1,000 per day) are maintained.
For the American immunologist, one of the main concerns today is the fight against the English variant.
To discover
Test, isolation: the procedure to follow in the event of a suspicion of Covid-19
There is a fight between the vaccine and the virus.
Anthony Fauci, public health adviser to Joe Biden
“
There is a variant in the United States, which is also present in France and in Europe, it is the B117 originating in the United Kingdom, and that makes it much more difficult to control the epidemic, because we know that the virus spreads more efficiently from person to person,
”explains Anthony Fauci at
JDD
.
Read also: Covid-19: Joe Biden speeds up vaccination by forced march across the United States
For him, this variant complicates the battle against Covid-19: "
We have a race against time between vaccination and this very contagious virus, which seems to be spreading even more effectively,
" he told the newspaper.
“
There is a fight between the vaccine and the virus.
Because we vaccinate 3 to 4 million people a day, we hope to get the situation under control within a reasonable time
”.
European Medicines Agency should clarify its position
In
the Sunday Journal
, the American public health adviser gives his opinion on the European vaccination campaign, which is struggling to accelerate.
According to him, "
European decision-makers should try to strengthen their contractual relations with vaccine producers
", as the United States is doing, by signing more contracts with large groups such as Pfizer, Moderna and Johnson & Johnson.
"
I think that the European Medicines Agency should clarify its position and issue recommendations on the way forward,
" he said of the controversy concerning certain side effects, in particular blood clots.
“
The agency seems to think there is a risk of side effects, but the benefit of the vaccine significantly outweighs the risk,” she says.
If so, then I think it should base its policy on these elements,
”he concludes.
Read also: Covid-19: the English variant would indeed lead to an increase in mortality
More than 100 million people have already received at least one dose of a Covid-19 vaccine in the United States, ten times more than in France.
